Detalhe da pesquisa
1.
The immune cell landscape in kidneys of patients with lupus nephritis.
Nat Immunol
; 20(7): 902-914, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209404
2.
Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.
Nat Immunol
; 20(10): 1404, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409923
3.
The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity.
Nat Immunol
; 16(5): 495-504, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25848864
4.
The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity.
Nat Immunol
; 14(9): 917-26, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23892722
5.
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial.
Ann Rheum Dis
; 83(3): 351-359, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123922
6.
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Kidney Int
; 95(1): 219-231, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420324
7.
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression.
Cancer Immunol Immunother
; 68(3): 421-432, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30564891
8.
Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.
J Am Soc Nephrol
; 29(11): 2619-2625, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30279272
9.
Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
J Am Soc Nephrol
; 28(4): 1175-1187, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821628
10.
Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina.
Am J Nephrol
; 45(5): 442-451, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445873
11.
The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.
Am J Nephrol
; 45(4): 365-372, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28315862
12.
Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.
Semin Immunol
; 25(3): 193-200, 2013 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23375135
13.
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
BMC Nephrol
; 18(1): 44, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143416
14.
Autoantigen complementarity and its contributions to hallmarks of autoimmune disease.
J Theor Biol
; 375: 88-94, 2015 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25526886
15.
Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.
Curr Opin Rheumatol
; 26(1): 42-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24276086
16.
Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial.
Arthritis Rheumatol
; 76(2): 247-254, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947366
17.
Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.
Nat Med
; 10(1): 72-9, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14661018
18.
Understanding the role of rituximab in ANCA GN: regressing toward the mean.
J Am Soc Nephrol
; 26(4): 771-4, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381425
19.
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Arthritis Rheumatol
; 73(1): 121-131, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755035
20.
Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis.
Ann Rheum Dis
; 74(9): 1784-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934841